Lactobacillus amylovorus inhibits the TLR4 inflammatory signaling triggered by enterotoxigenic Escherichia coli via modulation of the negative regulators and involvement of TLR2 in intestinal caco-2 cells and pig explants

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Finamore, Alberto ^a   Roselli, Marianna ^a   Imbinto, Ambra ^a   Seeboth, Julie ^b,c   Oswald, Isabelle P ^b,c   Mengheri, Elena ^a  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^b TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 90; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 1BETA; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN TOLLIP; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CACO 2 CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTEROTOXIGENIC ESCHERICHIA COLI; EXPLANT; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INHIBITION KINETICS; JEJUNUM; LACTOBACILLUS AMYLOVORUS; NEGATIVE FEEDBACK; NONHUMAN; PIGLET; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SUPERNATANT; UPREGULATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; INFLAMMATION; INTESTINE; LACTOBACILLUS ACIDOPHILUS; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PIG;

ANIMALS; CACO-2 CELLS; CELL NUCLEUS; CYTOKINES; ENTEROTOXIGENIC ESCHERICHIA COLI; HSP72 HEAT-SHOCK PROTEINS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINES; LACTOBACILLUS ACIDOPHILUS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; SUS SCROFA; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 84899641527     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094891     Document Type: Article

References (61)

1. Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124: 783-801.
2. Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21: 317-337.
3. O'Neill LA, Bryant CE, Doyle SL (2009) Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer. Pharm Rev 61: 177-197.
4. Lavelle EC, Murphy C, O'Neill LA, Creagh EM (2010) The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol 3: 17-28.
5. Long KZ, Rosado JL, Santos JI, Haas M, Al Mamun A, et al. (2010) Associations between mucosal innate and adaptive immune responses and resolution of diarrheal pathogen infections. Infect Immun 78: 1221-1228.
6. Moue M, Tohno M, Shimazu T, Kido T, Aso H, et al. (2008) Toll-like receptor 4 and cytokine expression involved in functional immune response in an originally established porcine intestinal epitheliocyte cell line. Biochim Biophys Acta 1780: 134-144.
7. Rakoff-Nahoum S, Pagina J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
8. Ogino T, Nishimura J, Barman S, Kayama H, Uematsu S, et al. (2013) Increased Th17-Inducing Activity of CD14(+) CD163(low) Myeloid Cells in Intestinal Lamina Propria of Patients With Crohn's Disease. Gastroenterology 145: 1380-1391.
9. Hausmann M, Kiessling S, Mestermann S, Webb G, Spöttl T, et al. (2002) Tolllike receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 122: 1987-2000.
10. Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, et al. (2005) Characteristics of intestinal dendritic cells in inflammatory bowel disease. Gastroenterology 129: 50-56.
11. Oyama J, Blais CJr, Liu X, Pu M, Kobzik L, et al. (2004) Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 109: 784-789.
12. Asea A (2008) Heat shock proteins and toll-like receptors. Handb Exp Pharmacol 183: 111-127.
13. Triantafilou M, Triantafilou K (2004) Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochem Soc Trans 32: 636-639.
14. Wheeler DS, Chase MA, Senft AP, Poynter SE, Wong HR, et al. (2009) Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respir Res 10: 31.
15. Chase MA, Wheeler DS, Lierl KM, Hughes VS, Wong HR, et al. (2007) Hsp72 induces inflammation and regulates cytokine production in airway epithelium through a TLR4-and NF-{kappa}B dependent mechanism. J Immunol 179: 6318-6324.
16. Chung SW, Lee JH, Choi KH, Park YC, Eo SK, et al. (2009) Extracellular heat shock protein 90 induces interleukin-8 in vascular smooth muscle cells. Biochem Biophys Res Commun 378: 444-449.
17. Asea A (2007) Hsp72 release: mechanisms and methodologies. Methods 43: 194-198.
18. Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS (2005) Differential induction of the toll-like receptor 4-MyD88-dependent and-independent signaling pathways by endotoxins. Infect Immun 73: 2940-2950.
19. Zeytun A, Chaudhary A, Pardington P, Cary R, Gupta G (2010) Induction of cytokines and chemokines by Toll-like receptor signaling: strategies for control of inflammation. Crit Rev Immunol 30: 53-67.
20. Medvedev AE, Kopydlowski KM, Vogel SN (2000) Expression chemokine, and toll-like receptor 2 and 4 gene macrophages: Deregulation of cytokine, transduction in endotoxin-tolerated mouse inhibition of lipopolysaccharideinduced signal. J Immunol 164: 5564-5574.
21. Haddad JJ, Abdel-Karim NE (2011) NF-kB cellular and molecular regulatory mechanisms and pathways: Therapeutic pattern or pseudo-regulation. Cell Immunol 271: 5-14.
22. O'Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364.
23. Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT, et al. (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr 140: 690S-697S.
24. Roselli M, Finamore A, Nuccitelli S, Carnevali P, Brigidi P, et al. (2009) Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of cdT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bow Dis 15: 1526-1536.
25. Finamore A, Roselli M, Britti MS, Merendino N, Mengheri E (2012) Lactobacillus rhamnosus GG and Bifidobacterium animalis MB5 induce intestinal but not systemic antigen-specific hyporesponsiveness in ovalbumin immunized rats. J. Nutr. 142: 375-381.
26. Bermudez-Brito M, Munoz-Quezada S, Gomez-Llorente C, Matencio E, Bernal MJ, et al. (2013) Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLoS One 8: e59370.
27. Shimazu T, Villena J, Tohno M, Fujie H, Hosoya S, et al. (2012) Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infect Immun 80: 276-288.
28. Vizoso Pinto MG, Rodriguez Gómez M, Seifert S, Watzl B, Holzapfel WH, et al. (2009) Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro. Int J Food Microbiol 133: 86-93.
29. Roselli M, Finamore A, Britti MS, Konstantinov SR, Smidt H, et al. (2007) The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. J Nutr 137: 2709-2716.
30. Konstantinov SR, Smidt H (2006) Commensal microbiota is required for the normal development and function of the porcine host immune system and physiology. In: Mengheri E, editor. Nutrition and immunity. Kerala (India): Research Signpost, p. 23-38.
31. Martinez RC, Aynaou AE, Albrecht S, Schols HA, De Martinis EC, et al. (2011) In vitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12. Int J Food Microbiol 149: 152-158.
32. Pinton P, Tsybulskyy D, Lucioli J, Laffitte J, Callu P, et al (2012) Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junctions proteins and MAPKinases. Tox Sci 130: 180-190.
33. Grenier B, Loureiro-Bracarense AP, Lucioli J, Drociunas-Pacheco G, Cossalter AM, et al (2011) Individual and combined effects of subclinical doses of deoxynivalenol and fumonisins in piglets. Mol Nutr Food Res 55: 761-771.
34. Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, et al. (1994) Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci 107: 213-225.
35. Caro I, Boulenc X, Rousset M, Meunier V, Bourrié M, et al. (1995) Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs. Int J Pharm 116: 147-158.
36. Kolf-Clauw M, Castellote J, Joly B, Bourges-Abella N, Raymond-Letron I, et al. (2009) Development of a pig jejunal explant culture for studying the gastrointestinal toxicity of the mycotoxin deoxynivalenol: histopathological analysis. Toxicol In Vitro 23: 1580-1584.
37. Konstantinov SR, Poznanski E, Fuentes S, Akkermans AD, Smidt H, et al. (2006) Lactobacillus sobrius sp. nov., abundant in the intestine of weaning piglets. Int J Syst Evol Microbiol 56: 29-32.
38. Lehto EM, Salminen SJ (1997) Inhibition of Salmonella typhimurium adhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture supernate: only a pH effect? FEMS Immunol Med Microbiol 18: 125-132.
39. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451.
40. Fort MM, Mozaffarian A, Stöver AG, Correia Jda S, Johnson DA, et al. (2005) A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immunol 174: 6416-6423.
41. Liu Y, Chen F, Odle J, Lin X, Jacobi SK, et al. (2012) Fish oil enhances intestinal integrity and inhibits TLR4 and NOD2 signaling pathways in weaned pigs after LPS challenge. J Nutr 142: 2017-2024.
42. Ohland CL, Macnaughton WK (2010) Probiotic bacteria and intestinal epithelial barrier function. Am J Physiol Gastrointest Liver Physiol 8: G807-G819.
43. Konstantinov SR, Smidt H, Akkermans AD, Casini L, Trevisi P, et al. (2008) Feeding of Lactobacillus sobrius reduces Escherichia coli F4 levels in the gut and promotes growth of infected piglets. FEMS Microbiol Ecol 66: 599-607.
44. Newton K, Dixit VM (2012) Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4: a006049.
45. Cammarota M, De Rosa M, Stellavato A, Lamberti M, Marzaioli I, et al. (2009) In vitro evaluation of Lactobacillus plantarum DSMZ 12028 as a probiotic: emphasis on innate immunity. Int J Food Microbiol 135: 90-98.
46. Liu Y, Fatheree NY, Mangalat N, Rhoads JM (2012) Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-kB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 302: G608-G617.
47. Wang S, Ng LH, Chow WL, Lee YK (2008) Infant intestinal Enterococcus faecalis down-regulates inflammatory responses in human intestinal cell lines. World J Gastroenterol 14: 1067-1076.
48. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K (2002) Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115: 2603-2611.
49. Bermudez-Brito M, Plaza-D?az J, Mun,oz-Quezada S, Gomez-Llorente C, Gil A (2012) Mechanisms of action of probiotics. Ann Nutr Metab 61: 160-174.
50. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202.
51. Zhang G, Ghosh S (2002) Negative regulation of toll-like receptor-mediated signaling by Tollip. J Biol Chem 277: 7059-7065.
52. Didierlaurent A, Brissoni B, Velin D, Aebi N, Tardivel A, et al. (2006) Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide. Mol Cell Biol 26: 735-742.
53. Otte JM, Cario E, Podolsky DK (2004) Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054-1070.
54. Deng JC, Cheng G, Newstead MW, Zeng X, Kobayashi K, et al. (2006) Sepsisinduced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest 116: 2532-2542.
55. Lagler H, Sharif O, Haslinger I, Matt U, Stich K, et al. (2009) TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol 183: 2027-2036.
56. Takanashi N, Tomosada Y, Villena J, Murata K, Takahashi T, et al. (2013) Advanced application of bovine intestinal epithelial cell line for evaluating regulatory effect of lactobacilli against heat-killed enterotoxigenic Escherichia colimediated inflammation. BMC Microbiol 13: 54.
57. Hosoya S, Villena J, Chiba E, Shimazu T, Suda Y, et al. (2013) Advanced application of porcine intestinal epithelial cells for the selection of immunobiotics modulating toll-like receptor 3-mediated inflammation. J Microbiol Immunol Infect 46: 474-481.
58. Biswas A, Wilmanski J, Forsman H, Hrncir T, Hao LH (2011) Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur J Immunol 41: 182-194.
59. Villena J, Suzuki R, Fujie H, Chiba E, Takahashi T, et al. (2012) Immunobiotic Lactobacillus jensenii modulates the Toll-like receptor 4-induced inflammatory response via negative regulation in porcine antigen-presenting cells. Clin Vaccine Immunol 19: 1038-1053.
60. Rizzo A, Losacco A, Carratelli CR, Domenico MD, Bevilacqua N (2013) Lactobacillus plantarum reduces Streptococcus pyogenes virulence by modulating the IL-17, IL-23 and Toll-like receptor 2/4 expressions in human epithelial cells. Int Immunopharmacol 17: 453-461.
61. Cario E, Gerken G, Podolsky DK (2007) Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 132: 1359-1374.